Genufood Energy Enzymes Corporation (GFOO) financial statements (2021 and earlier)
Company profile
| Business Address |
1108 S. BALWAIN AVENUE, SUITE 107 ARCADIA, CA 91007 |
| State of Incorp. | NV |
| Fiscal Year End | September 30 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2020 TTM | 9/30/2020 | 9/30/2019 | 9/30/2013 | 9/30/2012 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 189 | 18 | 122 | 871 | 1,167 | ||
| Cash and cash equivalents | 189 | 18 | 122 | 871 | 1,167 | ||
| Receivables | 0 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 111 | 94 | |||||
| Inventory | 111 | 94 | |||||
| Prepaid expense | 40 | ✕ | |||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 1 | ||
| Income taxes receivable | ✕ | ✕ | ✕ | 4 | 11 | ||
| Other current assets | 0 | ✕ | |||||
| Other undisclosed current assets | 2 | 1 | |||||
| Total current assets: | 189 | 18 | 122 | 1,027 | 1,273 | ||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 90 | 5 | |||||
| Intangible assets, net (including goodwill) | 78 | 63 | |||||
| Intangible assets, net (excluding goodwill) | 78 | 63 | |||||
| Deposits noncurrent assets | 48 | 35 | |||||
| Other undisclosed noncurrent assets | 800 | (48) | (35) | ||||
| Total noncurrent assets: | 800 | 168 | 69 | ||||
| TOTAL ASSETS: | 989 | 18 | 122 | 1,196 | 1,341 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 153 | 155 | 143 | 109 | 66 | ||
| Accounts payable | 131 | 129 | 129 | 101 | 16 | ||
| Accrued liabilities | 22 | 25 | 14 | 8 | 50 | ||
| Debt | 30 | 120 | |||||
| Due to related parties | 121 | 96 | 211 | 143 | 74 | ||
| Other undisclosed current liabilities | 55 | ||||||
| Total current liabilities: | 359 | 371 | 354 | 252 | 140 | ||
| Noncurrent Liabilities | |||||||
| Total liabilities: | 359 | 371 | 354 | 252 | 140 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | 630 | (353) | (232) | 944 | 1,201 | ||
| Common stock | 211 | 104 | 7,325 | 394 | 393 | ||
| Common stock, share subscribed but unissued, subscriptions receivable | (500) | (2,111) | |||||
| Additional paid in capital | 16,092 | 15,135 | 4,997 | 3,712 | 3,891 | ||
| Accumulated other comprehensive loss | (195) | (192) | (191) | (8) | (1) | ||
| Accumulated deficit | (8,236) | (8,158) | (7,847) | ||||
| Other undisclosed stockholders' equity attributable to parent | (7,242) | (7,242) | (4,517) | (2,654) | (971) | ||
| Total stockholders' equity: | 630 | (353) | (232) | 944 | 1,201 | ||
| TOTAL LIABILITIES AND EQUITY: | 989 | 18 | 122 | 1,196 | 1,341 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2020 TTM | 9/30/2020 | 9/30/2019 | 9/30/2013 | 9/30/2012 | ||
|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 41 | 61 | ||||
| Cost of revenue (Cost of Goods and Services Sold) | (21) | (43) | ||||
| Gross profit: | 20 | 18 | ||||
| Operating expenses | (314) | (310) | (304) | (1,701) | (462) | |
| Operating loss: | (314) | (310) | (304) | (1,681) | (444) | |
| Nonoperating income (expense) | (2) | (1) | (0) | (2) | 1 | |
| Investment income, nonoperating | (0) | 0 | 1 | 1 | ||
| Foreign currency transaction gain (loss), before tax | (0) | (0) | (0) | (3) | 0 | |
| Other nonoperating income | 0 | |||||
| Interest and debt expense | (1) | (1) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (317) | (312) | (304) | (1,683) | (443) | |
| Other undisclosed income from continuing operations before income taxes | 1 | 1 | ||||
| Loss before gain (loss) on sale of properties: | (316) | (311) | (304) | (1,683) | (443) | |
| Other undisclosed net income | 607 | |||||
| Net income (loss): | (316) | (311) | 304 | (1,683) | (443) | |
| Other undisclosed net loss attributable to parent | (607) | |||||
| Net loss available to common stockholders, diluted: | (316) | (311) | (304) | (1,683) | (443) | |
Comprehensive Income ($ in thousands)
| 12/31/2020 TTM | 9/30/2020 | 9/30/2019 | 9/30/2013 | 9/30/2012 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (316) | (311) | 304 | (1,683) | (443) | |
| Other undisclosed comprehensive income (loss) | (7) | 0 | ||||
| Comprehensive income (loss): | (316) | (311) | 304 | (1,691) | (442) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (2) | (1) | (606) | |||
| Comprehensive loss, net of tax, attributable to parent: | (318) | (312) | (303) | (1,691) | (442) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.